Artrya (ASX:AYA) Price-to-Operating-Cash-Flow : (As of Jun. 02, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Artrya Price-to-Operating-Cash-Flow?

As of today (2025-06-02), Artrya's share price is A$0.73. Artrya's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.15. Hence, Artrya's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Artrya's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:AYA's Price-to-Operating-Cash-Flow is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 11.77
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Artrya's Cash Flow from Operations per share for the six months ended in Dec. 2024 was A$-0.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.15.

Artrya Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Artrya's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Price-to-Operating-Cash-Flow Chart

Artrya Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Price-to-Operating-Cash-Flow

Artrya Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Artrya's Price-to-Operating-Cash-Flow

For the Health Information Services subindustry, Artrya's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artrya's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Artrya's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Artrya's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Artrya Price-to-Operating-Cash-Flow Calculation

Artrya's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.73	/	-0.153
	=

Artrya's Share Price of today is A$0.73.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Artrya's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.15.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Artrya Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Artrya's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Artrya Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

1257 Hay Street, West Perth, Perth, WA, AUS, 6005

Website

https://www.artrya.com

Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines